Lipocine Cash And Short Term Investments from 2010 to 2025

LPCN Stock  USD 3.54  0.04  1.14%   
Lipocine Cash And Short Term Investments yearly trend continues to be very stable with very little volatility. Cash And Short Term Investments are likely to grow to about 26.4 M this year. Cash And Short Term Investments is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. View All Fundamentals
 
Cash And Short Term Investments  
First Reported
2011-12-31
Previous Quarter
19.8 M
Current Value
21.6 M
Quarterly Volatility
13.6 M
 
Yuan Drop
 
Covid
Check Lipocine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipocine's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 5.8 M or Total Revenue of 11.8 M, as well as many indicators such as Price To Sales Ratio of 2.21, Dividend Yield of 0.0 or PTB Ratio of 1.3. Lipocine financial statements analysis is a perfect complement when working with Lipocine Valuation or Volatility modules.
  
Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.

Latest Lipocine's Cash And Short Term Investments Growth Pattern

Below is the plot of the Cash And Short Term Investments of Lipocine over the last few years. Short Term Investments is an account in the current assets section of Lipocine balance sheet. This account contains Lipocine investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Lipocine fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Lipocine's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lipocine's overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments10 Years Trend
Slightly volatile
   Cash And Short Term Investments   
       Timeline  

Lipocine Cash And Short Term Investments Regression Statistics

Arithmetic Mean22,614,202
Geometric Mean5,522,506
Coefficient Of Variation65.56
Mean Deviation11,169,740
Median22,035,546
Standard Deviation14,826,546
Sample Variance219.8T
Range45.3M
R-Value0.36
Mean Square Error205.6T
R-Squared0.13
Significance0.18
Slope1,109,226
Total Sum of Squares3297.4T

Lipocine Cash And Short Term Investments History

202526.4 M
202421.6 M
202322 M
202232.5 M
202144.6 M
202019.7 M
201914.1 M

About Lipocine Financial Statements

Lipocine investors utilize fundamental indicators, such as Cash And Short Term Investments, to predict how Lipocine Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cash And Short Term Investments21.6 M26.4 M
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
2.097
Quarterly Revenue Growth
15.15
Return On Assets
(0.03)
Return On Equity
0.0004
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.